Psychedelic Stocks Archives - Page 8 of 61

ThursdayJul 11, 2024 10:00 am

Studies Find Tripping, Microdosing Psilocybin Mushrooms Is Growing

Recently released reports suggest that hallucinogenic mushrooms may be the most popular psychedelic drug of choice for the public. The reports also determined that most individuals preferred microdosing over a full trip, with one study observing a 1,250% increase in internet search history on microdosing. The study, which also found that psilocybin searches began outpacing LSD in 2019, was conducted by epidemiologist Eric Leas. The study also determined that the increase in curiosity on microdosing correlated with changes in policies related to both psychedelics and marijuana. In his study, Leas observed that the more liberal a state became related to…

TuesdayJul 02, 2024 10:00 am

CU Denver Unveils Psychedelic Research Center

The University of Colorado Denver recently launched the CU Denver Center for Psychedelic Research. This center is focused on improving the quality of life of individuals by conducting research on the potential benefits psychedelics may possess in the treatment of various mental, neurological, emotional and other health conditions as well as their possible use in the management of chronic, debilitating illnesses such as cancer. Professor Jim Grigsby, executive director and the center’s chief science officer, revealed that a national study was going on and the center was also planning a number of other studies. Grigsby, who teaches psychology at CU…

ThursdayJun 27, 2024 10:00 am

Older Psychedelics Users Reveal Fascinating Brain Function, Study Says

Scientific interest in psychedelics has increased greatly over the past few years as more and more trials determine that these substances possess the therapeutic potential to treat disorders such as post traumatic stress disorder (PTSD), depression or anxiety. Substances with the most promising results include LSD, psilocybin, MDMA and ketamine. Now, results from a recently conducted survey show that psychedelic drugs such as LSD, MDMA and psilocybin may help protect the brain from some features of aging. The survey was carried out in the United States and involved 3,294 adults, all aged between 42 and 92 years of age. The…

ThursdayJun 20, 2024 10:00 am

UC Berkeley Research to Investigate How Psychedelics Alter People’s Views

Psychedelic fungi and plants have been used by various Indigenous communities in their healing and spiritual ceremonies for millennia. In the 1950s and 1960s, western therapists, psychiatrists and researchers began looking into whether these drugs could be used to manage mental-health conditions. However, the approval of the Controlled Substances Act halted this research, up until about a decade ago. Now, researchers at the UC Berkeley Center for the Science of Psychedelics are set to begin a study looking into how psychedelic substances shape how humans perceive things. Previous research has determined that the effects of these drugs on an individual’s…

TuesdayJun 18, 2024 10:00 am

Study Suggests Psychedelics Reduce Fear of Death by Impacting Metaphysical Beliefs

Therapeutic interest in psychedelics has grown as researchers learn more about the potential of these substances to manage the symptoms of different mental-health conditions and improve the well-being of individuals. Now, new research has determined that psychedelic experiences can cause a decrease in death anxiety, possibly by changing a person’s metaphysical beliefs. This discovery creates new approaches for understanding how these substances may help people deal with existential fears. For their study, researchers focused on determining if changes in core beliefs on consciousness and the nature of reality could be a key factor in decreasing death anxiety after psychedelics were…

ThursdayJun 13, 2024 10:00 am

Study Finds That Psychedelics, Religion Weaken Link to Risky Behavior and Violence

Classic psychedelics are drugs that induce altered states of consciousness and intense auditory and visual hallucinations when ingested. Common classic psychedelics include psilocybin, LSD, DMT and mescaline. These drugs have been used for centuries by Indigenous peoples in spiritual ceremonies and healing practices. In most countries, psychedelics are illegal. Despite their status, various studies have determined that these drugs hold promise in the treatment of conditions such as anxiety, depression and post-traumatic stress disorder (PTSD). Now, new research has determined that the link between violence and risky behaviors is weaker among individuals who report lifetime psychedelic use as well as…

TuesdayJun 11, 2024 10:00 am

Psychedelic Stocks Fall as Advisory Panel Tells FDA Not to Approve MDMA

A number of companies involved in the psychedelic space saw their stocks plummet during premarket trading earlier this week after an advisory panel counseled the U.S. Food and Drug Administration (FDA) against approving the use of MDMA as a treatment for post traumatic stress disorder (PTSD). MDMA, commonly known as molly or ecstasy, is a stimulant and psychedelic drug that comes in powder or pill forms. Currently, the drug is classified under Schedule I of the Controlled Substances Act, together with drugs such as LSD, marijuana, heroin and peyote. Drugs under this classification are said to have no accepted medical…

ThursdayJun 06, 2024 10:00 am

Case Study Documents Psychedelics Aiding Patient’s Recovery from Long-COVID

Long-COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection, includes various symptoms that persist even after an individual recovers from the COVID-19. These symptoms include cognitive impairment, fatigue, depression, anxiety, headaches and joint pain. Currently, effective treatment options for long-COVID are limited. However, a new case study has examined how one patient suffering from long-COVID used MDMA and psilocybin to manage her symptoms. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. It has been used by indigenous cultures for spiritual ceremonies for centuries. In the last few years, scientific research has discovered that psilocybin has therapeutic benefits…

TuesdayJun 04, 2024 10:00 am

Could Psychedelics Help Individuals Who Stutter?

A new study looking into the effect of psychedelics on individuals who stutter has determined that the drugs may have some benefits. The documented effects of classic psychedelic drugs such as LSD or psilocybin mushrooms are plenty, with researchers noting that their positive effects can be a rich study area. Eric S. Jackson, an associate professor of communicative disorders and sciences, states that investigating the possible effects of psychedelics on stuttering can be positive, particularly since the drugs have already shown potential in the management of conditions such as post-traumatic stress disorder and anxiety. Stuttering is basically intermittent disruptions in…

ThursdayMay 30, 2024 10:00 am

Study Offers Insights on Colorado’s Plans to Monitor, Regulate Psychedelics

The state of Colorado is pioneering the way once more as government leaders figure out how to establish and regulate the nascent psychedelics industry. The state was the first to legalize the recreational use of marijuana. This latest move comes after Colorado became one of the first states in the country to legalize psychedelic drugs and establish policy around their therapeutic use. Denver Health and Hospital Authority’s Joshua Black stated that while psychedelics had been used for millennia, this was the first time the substances were being approved for use by trained practitioners. Black is a senior research scientist at…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks